Načítá se...

CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model

BACKGROUND: GPRC6A is implicated in the pathogenesis of prostate cancer, but its role remains uncertain because of a purported tolerant gene variant created by substitution of a K..Y polymorphism in the 3rd intracellular loop (IL) that evolved in the majority of humans and replaces the ancestral RKL...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Exp Clin Cancer Res
Hlavní autoři: Ye, Ruisong, Pi, Min, Cox, John V., Nishimoto, Satoru K., Quarles, L. Darryl
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490090/
https://ncbi.nlm.nih.gov/pubmed/28659174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0561-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!